Investor Relations

Recent News
Jan 5, 2021

Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, today announced that President and Chief Executive...

Dec 7, 2020

--Retrospective analyses of the Phase 3 SIMPLIFY studies demonstrate safety and activity profile are not impacted by baseline platelet count-- VANCOUVER, BC, Dec. 7, 2020 /CNW/ - Sierra Oncology,...

Dec 5, 2020

--Momelotinib demonstrates robust overall survival in both JAKi-naïve and patients previously treated with ruxolitinib-- VANCOUVER, BC, Dec. 5, 2020 /CNW/ - Sierra Oncology, Inc. (SRRA), a...

View all news releases

Events and Webcasts
Monday, January 11, 2021 - Thursday, January 14, 2021

The presentation will be available online beginning at 6:00 am ET on Monday, January 11, 2021 via the link.

View all events and webcasts

Investor Enquiries

Dede Sheel
Vice President, Investor Relations
investors@sierraoncology.com

Sign up for investor alerts